PL2892528T3 - Kompozycje farmaceutyczne zawierające flurbiprofen - Google Patents

Kompozycje farmaceutyczne zawierające flurbiprofen

Info

Publication number
PL2892528T3
PL2892528T3 PL13836176T PL13836176T PL2892528T3 PL 2892528 T3 PL2892528 T3 PL 2892528T3 PL 13836176 T PL13836176 T PL 13836176T PL 13836176 T PL13836176 T PL 13836176T PL 2892528 T3 PL2892528 T3 PL 2892528T3
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
compositions containing
containing flurbiprofen
flurbiprofen
pharmaceutical
Prior art date
Application number
PL13836176T
Other languages
English (en)
Inventor
Tim Shea
Adrian Shephard
Gary Smith
Sue Aspley
Bernard P Schachtel
Original Assignee
Reckitt Benckiser Healthcare International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47137098&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2892528(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare International Ltd filed Critical Reckitt Benckiser Healthcare International Ltd
Publication of PL2892528T3 publication Critical patent/PL2892528T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL13836176T 2012-09-07 2013-09-09 Kompozycje farmaceutyczne zawierające flurbiprofen PL2892528T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261697901P 2012-09-07 2012-09-07
GBGB1215988.5A GB201215988D0 (en) 2012-09-07 2012-09-07 Pharmaceutical compositions comprising flurbiprofen
EP13836176.1A EP2892528B1 (en) 2012-09-07 2013-09-09 Pharmaceutical compositions comprising flurbiprofen
PCT/US2013/058685 WO2014039939A1 (en) 2012-09-07 2013-09-09 Pharmaceutical compositions comprising flurbiprofen

Publications (1)

Publication Number Publication Date
PL2892528T3 true PL2892528T3 (pl) 2019-11-29

Family

ID=47137098

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13836176T PL2892528T3 (pl) 2012-09-07 2013-09-09 Kompozycje farmaceutyczne zawierające flurbiprofen

Country Status (12)

Country Link
US (5) US20150231063A1 (pl)
EP (1) EP2892528B1 (pl)
KR (2) KR20200131913A (pl)
AU (1) AU2013312259B2 (pl)
BR (1) BR112015004115A2 (pl)
ES (1) ES2742034T3 (pl)
GB (1) GB201215988D0 (pl)
MX (1) MX363558B (pl)
PL (1) PL2892528T3 (pl)
RU (2) RU2015112586A (pl)
WO (1) WO2014039939A1 (pl)
ZA (1) ZA201501553B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US5322689A (en) * 1992-03-10 1994-06-21 The Procter & Gamble Company Topical aromatic releasing compositions
US20030206942A1 (en) 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
PL2106258T3 (pl) * 2006-10-20 2012-11-30 Bayer Consumer Care Ag Ibuprofen przeciwko kaszlowi
GB2453770A (en) * 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
JP5877204B2 (ja) * 2010-09-29 2016-03-02 パルマトリックス，インコーポレイテッド 吸入用の一価金属カチオン乾燥粉末
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation

Also Published As

Publication number Publication date
WO2014039939A1 (en) 2014-03-13
GB201215988D0 (en) 2012-10-24
US20200163871A1 (en) 2020-05-28
US20180110723A1 (en) 2018-04-26
US20220008331A1 (en) 2022-01-13
MX363558B (es) 2019-03-27
RU2019102890A (ru) 2019-05-07
BR112015004115A2 (pt) 2017-07-04
AU2013312259B2 (en) 2018-06-07
KR20150048890A (ko) 2015-05-07
KR20200131913A (ko) 2020-11-24
EP2892528A1 (en) 2015-07-15
ZA201501553B (en) 2017-08-30
RU2015112586A (ru) 2016-10-27
ES2742034T3 (es) 2020-02-12
EP2892528A4 (en) 2016-04-13
MX2015002946A (es) 2015-06-02
US20150231063A1 (en) 2015-08-20
AU2013312259A1 (en) 2015-04-09
EP2892528B1 (en) 2019-05-15
US20190070101A1 (en) 2019-03-07

Similar Documents

Publication Publication Date Title
DK3181122T3 (da) Farmaceutisk dasatinib-sammensætning
SMT201600350B (it) Composizioni farmaceutiche
BR112014003052A2 (pt) composições farmacêuticas
DK2694038T3 (da) Farmaceutisk sammensætning
EP3488847C0 (en) SEMIFLUORINATED ALKANE COMPOSITIONS
PL3156056T3 (pl) Kompozycje farmaceutyczne zawierające estry sorbitanu
CO6930367A2 (es) Composiciones farmaceúticas
DK3246018T3 (da) Farmaceutisk sammensætning
BR112015002651A2 (pt) composições cosméticas
BR112014032798A2 (pt) composição
EP2893918A4 (en) ORAL COMPOSITION
ME03413B (me) Kompozicije које sadrže peg i askorbat
EE201300005A (et) Ravimkoostis
HUE040370T2 (hu) Gyógyszerkészítmények
EP2702989A4 (en) STABLE PHARMACEUTICAL COMPOSITION
DK2897594T3 (da) Farmaceutisk sammensætning
DK2815752T3 (da) Oral farmaceutisk sammensætning
BR112015003116A2 (pt) preparação farmacêutica sólida contendo levotiroxina
CO6801722A2 (es) Composiciones farmacéuticas
EP2815753A4 (en) ORAL PHARMACEUTICAL COMPOSITION
EP2769718A4 (en) MEDICAL COMPOSITION
PL2908835T3 (pl) Stabilne formulacje
BR112014032712A2 (pt) composição
EP2851085A4 (en) STERILIZED COMPOSITION
BR112015002646A2 (pt) composto e composição farmacêutica